David Shaw’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

David Shaw’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-459,500	Closed	-$4.63M	–	5177
2022 Q4	$4.63M	Buy	459,500 +139,076	+43%	+$1.39M	0.01%	2172
2022 Q3	$3.17M	Buy	320,424 +2,858	+0.9%	+$28.2K	﹤0.01%	2579
2022 Q2	$3.11M	Buy	317,566 +30,817	+11%	+$302K	﹤0.01%	2674
2022 Q1	$2.8M	Sell	286,749 -115,506	-29%	-$1.12M	﹤0.01%	2968
2021 Q4	$3.91M	Buy	402,255 +230,190	+134%	+$2.24M	﹤0.01%	2657
2021 Q3	$1.68M	Buy	+172,065	New	+$1.66M	﹤0.01%	3189

David Shaw's MSAC Position: Q1 2023 in Review

David Shaw sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 459,500 shares — an estimated $4.63M sold.

David Shaw first reported a position in MSAC in Q3 2021 and held it in 6 quarters. The position peaked at $4.63M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

David Shaw reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
David Shaw sold 459,500 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $4.63M.
David Shaw first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
David Shaw's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $4.63M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.